← FDA DRUG APPROVALS

FDA ANDA · ANDA074603

GENERLAC

lactulose

Sponsor: CHARTWELL RX

APPLICATION
ANDA074603
TYPE
ANDA
ORIGINAL APPROVAL
1996-10-31
LATEST ACTION
2001-11-26
ROUTE
ORAL, RECTAL, ORAL, RECTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

GENERLACPrescription
LACTULOSE 10GM/15ML · SOLUTION · ORAL, RECTAL

Approval history

2001-11-26Labeling · Supplement 5AP
2001-04-05Labeling · Supplement 4AP
2000-04-14Manufacturing (CMC) · Supplement 1AP
2000-04-14Manufacturing (CMC) · Supplement 2AP
1999-07-15Labeling · Supplement 3AP
1996-10-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →